C1498: A Murine Model for Acute Myelogenous Leukemia (AML)

Acute myelogenous leukemia (AML) is a rapidly progressing malignancy of myeloid white blood cells.  An estimated 21,380 new cases of AML and 10,590 deaths will occur in the United States in 2017. AML results from excessive proliferation of dedifferentiated or undifferentiated myeloid leukocytes initially in the bone marrow. As disease progresses, AML blast cells will … Continue reading C1498: A Murine Model for Acute Myelogenous Leukemia (AML)